Frontlight ResearchEarly access
Trial site
American Heart of Poland S.A.
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- Atrial fibrillation2 trials
- Obesity2 trials
- Coronary artery disease1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Lead sponsor
- Novo Nordisk A/S3 trials
- Acesion Pharma1 trial
- Anthos Therapeutics, Inc.1 trial
- Medical University Of Warsaw1 trial
- Shionogi Inc.1 trial
- and 1 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Recruiting
Active, not recruiting
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure
Active, not recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Atrial fibrillation1 recruiting
- Coronary artery disease1 recruiting
- Heart failure1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026